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Human Periodontal Ligament- and Gingiva-derived Mesenchymal Stem Cells
Promote Nerve Regeneration When Encapsulated in Alginate/hyaluronic Acid 3D
Scaffold
Abstract
Repair or regeneration of damaged nerves is still a challenging clinical task in reconstructive surgeries
and regenerative medicine. Here, we demonstrate that periodontal ligament stem cells (PDLSCs) and
gingival mesenchymal stem cells (GMSCs) isolated from adult human periodontal and gingival tissues
assume neuronal phenotype in vitro and in vivo via a subcutaneous transplantation model in nude mice.
PDLSCs and GMSCs were encapsulated in a three-dimensional scaffold based on alginate and hyaluronic
acid hydrogels capable of sustained release of human nerve growth factor (NGF). We demonstrate that,
the elasticity of the hydrogels affected the proliferation and differentiation of encapsulated MSCs within
scaffolds. Moreover, we observed that PDLSCs and GMSCs were stained positive for βIII-tubulin, while
exhibiting high levels of gene expression related to neurogenic differentiation (βIII-tubulin and GFAP) via
qPCR. Western blot analysis showed the importance of the elasticity of the matrix and the presence of
NGF in the neurogenic differentiation of encapsulated MSCs. In vivo, immunofluorescence staining for
neurogenic specific protein markers confirmed islands of dense positively stained structures inside
transplanted hydrogels. To our knowledge, this study is the first demonstration of the application of
PDLSCs and GMSCs as promising cell therapy candidates for nerve regeneration.
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Abstract
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Repair or regeneration of damaged nerves is still a challenging clinical task in reconstructive
surgeries and regenerative medicine. Here, we demonstrate that periodontal ligament stem cells
(PDLSCs) and gingival mesenchymal stem cells (GMSCs) isolated from adult human periodontal
and gingival tissues assume neuronal phenotype in vitro and in vivo via a subcutaneous
transplantation model in nude mice. PDLSCs and GMSCs were encapsulated in a threedimensional scaffold based on alginate and hyaluronic acid hydrogels capable of sustained release
of human nerve growth factor (NGF). We demonstrate that, the elasticity of the hydrogels affected
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the proliferation and differentiation of encapsulated MSCs within scaffolds. Moreover, we
observed that PDLSCs and GMSCs were stained positive for !III-tubulin, while exhibiting high
levels of gene expression related to neurogenic differentiation (!III-tubulin and GFAP) via qPCR.
Western blot analysis showed the importance of the elasticity of the matrix and the presence of
NGF in the neurogenic differentiation of encapsulated MSCs. In vivo, immunofluorescence
staining for neurogenic specific protein markers confirmed islands of dense positively stained
structures inside transplanted hydrogels. To our knowledge, this study is the first demonstration of
the application of PDLSCs and GMSCs as promising cell therapy candidates for nerve
regeneration.

Graphical abstract

Author Manuscript
Author Manuscript

A 3D hydrogel delivery system is fabricated based on alginate and hyaluronic acid hydrogels, with
optimized elasticity. Periodontal Ligament Stem Cells (PDLSCs) and Gingival Mesenchymal Stem
Cells (GMSCs) are encapsulated in the engineered scaffold and it is demonstrated that
proliferation and differentiation of encapsulated MSCs toward neurogenic tissues is regulated by
matrix elasticity and the presence of a suitable signaling molecules. It is shown that these MSCs
encapsulated in a 3D injectable cell delivery scaffold might be promising candidates for cellularbased treatment for nerve tissue engineering.
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Alginate; Hyaluronic acid; Nerve regeneration; Dental-derived mesenchymal stem cells

1. Introduction

Author Manuscript

One of the most challenging obstacles in reconstructive surgery and regenerative medicine is
the regeneration and the repair of damaged nerves.[1,2] The inability to regenerate the lost
nerve tissue has detrimental consequences such as permanent loss of function or posttraumatic morbidity.[1,2] It is well known that the nervous system, both central and
peripheral, has a limited self-repair/regeneration potential. One of the common treatment
modalities for regeneration of nerve tissues is nerve autografting, in which a nerve graft is
harvested from a functionally less important nerve.[1–3] However, this treatment modality
has many drawbacks, such as donor site morbidity, the possibility of neuroma formation,
scarring, and the expense of the surgical procedure.[1–3] Cell replacement therapies have
shown promise as an alternative modality of treatment for nerve regeneration.[4–6] Studies
Adv Healthc Mater. Author manuscript; available in PMC 2018 December 01.
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have confirmed that embryonic stem cells (ESCs) are capable of differentiation toward most
neuronal subtypes as a promising cell source for nerve regeneration treatments.[7,8] As well
as induced pluripotent stem (iPS) cells, neural stem cells (NSCs) have also revealed potential
for use in nerve regeneration therapies.[9,10] Studies have confirmed the presence of NSCs
throughout life in both humans and animals. Currently, cell therapies are the best alternative
to a nerve graft.[9–11] However, in a situation where the gap at the defect site is too long,
these approaches may not lead to favorable outcomes.[10,11] Additionally, NSCs are not
always easy to access or isolate. Alternatively, mesenchymal stem cells (MSCs) can be
considered as a promising source of stem cells for nerve regeneration applications.[12–14]
MSCs are multipotent cells that, depending on the received signals from microenvironment,
can be differentiated into osteogenic, adipogenic, chondrogenic, neurogenic and other
lineages.[15–17] Several studies have shown that MSCs have the potential to differentiate into
functional neural cells, including astrocytes, neurons, and oligodendrocytes.[18–20] Several
of these reports on neurogenic differentiation have concentrated on bone marrow MSCs
(hBMMSCs). Though, hBMMSCs are identified to have a low and unpredictable
differentiation capacity relative to certain other types of MSCs.[13, 14, 18–20] Therefore, it
seems essential to find an optimal cell source for nerve regeneration and repair applications.

Author Manuscript

MSCs are found in a variety of post-natal structures, including many in the orofacial region.
[21–26] Numerous kinds of dental-derived MSCs have been extracted and characterized, such
as: periodontal ligament stem cells (PDLSCs) and more recently, gingival mesenchymal
stem cells (GMSCs).[21–26] These two categories of MSCs are easily available in the oral
cavity; indeed, they can also be found in dental clinics tissue waste.[27–30] Furthermore, our
group and others have confirmed their multilineage differentiation capabilities.[27–30]
Therefore, PDLSCs and GMSCs might be unique and promising cell types for nerve
regenerative therapies.

Author Manuscript

It’s very accepted that the microenvironment has a fundamental role in determining stem cell
fate.[31,32] Signals that cells receive from signaling molecules or from the extracellular
matrix (ECM) direct the differentiation of MSCs toward the desired lineage.[33,34]
Considering the three dimensional (3D) organized assembly of the central nervous system
(CNS), a 3D biomaterial seems to be necessary to provide a suitable microenvironment for
differentiation of encapsulated MSCs toward neurogenic tissues.[35] Several types of
biomaterials have been used as 3D delivery vehicles for MSCs. Among these biomaterials,
alginate hydrogel is one of the popular choices.[36, 37] Alginate is a natural
heteropolysaccharide derived from algae.[38, 39] Sodium alginate ionically crosslinks by
divalent cations (e.g. Ca2+). Alginate has found a wide variety of applications in
bioengineering based on its favorable features, including biocompatibility, non-toxicity, and
gentle gelation.[38, 39]
Alginate has been used successfully to direct differentiation of encapsulated MSCs or iPCSs
toward neural lineage phenotypes.[35, 40, 41] However, it is well known that alginate hydrogel
without any modification does not provide suitable cell adhesion.[38,39] Hence, to mimic the
cell-interactive characteristics of the ECM, cell binding motifs (e.g., RGD, an arginineglycine-aspartic acid tripeptide), have been coupled to it.[42,43] Another natural hydrogel
biomaterial that is a promising matrix for nerve regeneration is hyaluronic acid (HA), a
Adv Healthc Mater. Author manuscript; available in PMC 2018 December 01.
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glycosaminoglycan that is one of the important constituents of the ECM of the developing
CNS and neural stem cell niche.[45] Studies have confirmed the importance of this hydrogel
in promoting cell survival, migration, and differentiation for nerve regeneration.44–46
For successful tissue regeneration applications, the hydrogel biomaterial should possess
biomechanical properties close to those of the natural ECM to provide an optimal
environment for the growth and differentiation of encapsulated cells toward the desired
phenotype. To develop a suitable microenvironment for nerve regeneration based on
PDLSCs or GMSCs, we planned to engineer an RGD-conjugated alginate and hyaluronic
acid (HA)-based hybrid hydrogel scaffold with a low elastic modulus to direct neurogenic
differentiation of the encapsulated PDLSCs and GMSCs.

2. Results
Author Manuscript

2.1. Viability of encapsulated cells in HA/alginate hydrogels

Author Manuscript

In the current study, PDLSCs and GMSCs were isolated from periodontal or gingival tissues
of patients with healthy periodontium. The isolated MSCs were expanded in vitro,
encapsulated in one of the fabricated Hyaluronic acid (HA)/alginate hydrogels and utilized
for neurogenic differentiation assays in vitro and in vivo. Human BMMSCs were used as the
positive control, while cell-free hydrogels were used as the negative one. Subsequently, the
viability of the encapsulated MSCs and their neurogenic differentiation capacity were
analyzed. Our flow cytometric analysis data confirmed the stemness of these MSCs by
expression of specific MSC surface markers such as: CD73, CD105, and CD146 (not
shown), while, both of these cells failed to express hematopoietic lineage markers including
CD34 or CD45. MSCs were encapsulated in hydrogel scaffolds at a cell density of 1 × 106
cells/mL and the viability of MSCs was measured at three time intervals: after 1, 7 and 14
days of culturing. Our live/dead staining results exhibited high in vitro viability for PDLSCs,
GMSCs, and hBMMSCs encapsulated in fabricated hydrogels at different time intervals of
culturing in regular culture media (Figure 1a and 1b).
2.2. Characterization of fabricated hydrogels and analysis of cell proliferation

Author Manuscript

HA content affects properties of hydrogels including their elastic modulus and porosity. It is
well known that the elastic modulus of the matrix plays a role in directing the fate of
encapsulated cells.[53] Therefore, we fabricated and tested three different hydrogels with
different alginate/HA ratios (4:1, 2:1, and 1:1 w/w). Subsequently, the mechanical properties
of the fabricated hydrogels were characterized. The data exhibited in Figure 2a show the
elastic modulus of the fabricated hydrogels with different compositions. The formulation
with the highest concentration of HA (Alg/HA: 1:1) exhibited the lowest elastic modulus (5
KPa) of the four tested hydrogels. Alginate hydrogel alone showed the greatest elasticity (18
KPa). Additionally, the morphological structure of the fabricated hydrogels was analyzed
using SEM and our data confirmed a porous morphology (Figure 2b) with pore size ranging
from 45 µm to 89 µm. By increasing the ratio of hyaluronic acid in the hydrogel mixture
slight increase in the porosity was observed (Figure 2c).
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Moreover, we aimed to assess the influence of the elasticity of the 3D fabricated hydrogel on
the proliferation of encapsulated MSCs. All the encapsulated MSCs showed a significant
increase in the proliferation rate (cell number) after one week of culturing (Figure 2d).

Author Manuscript

It is well known that the proliferation rates of cells cultured in 3D and 2D can be different.
Studies have confirmed that decreased proliferation rate in 3D cultures in comparison to 2D
cultures for variety of cell lines.[61] In contrast, some other cell lines have exhibited an
opposite trend showing increased proliferation rates in 3D cultures than 2D ones.[61]
Interestingly, the proliferation rate of GMSCs increased with a decrease in the elasticity of
the fabricated hydrogels (Figure 2e). However, the proliferation rates of PDLSCs and
hBMMSCs seemed not to be significantly affected by changing the elasticity of the
encapsulation hydrogel (Figure 2f). The amount of increase in the proliferation rate for
MSCs cultured in a 2D monolayer without hydrogel after one week of culture was found to
be slower (data not shown here) than that of encapsulated MSCs, suggesting that scaffold
chemical composition and biomechanical properties influence cell proliferation.

Author Manuscript

In the next step, the release profile of the incorporated ! -NGF from the fabricated
alginate/HA hydrogels was characterized. Figure 3a shows the cumulative release of ! -NGF
from the HA/alginate hydrogel scaffolds. The results confirmed continued release of ! -NGF
for up to 14 days. An increase in growth factor release was observed from the alginate/
hyaluronic acid hydrogel with the highest concentration of HA; however, no significant
difference was observed in the release of the growth factor from the four tested scaffolds for
up to two weeks (p value >0.05). Moreover, immunofluorescent staining with the anti- ! NGF antibody showed that less ! -NGF was retained in Alg/HA (1:1) hydrogel than alginate
hydrogel without HA after 14 days (Figure 3b and 3c). Results of the swelling kinetics study
are presented in Figure 3d. It is well known that HA is a highly hydrophilic structure that
can swell easily.[60] Our data showed that by increasing the ratio of HA in the hydrogel
mixture, a decrease in swelling ratio was observed which is well related to the balance of the
ionic strengths between the polyanions and polycations in the alginate/HA hydrogel mixture.
[60]

2.3. In vitro differentiation of dental-derived MSCs

Author Manuscript

MSCs cultured in a 2D neurogenic inductive medium after 72h of incubation exhibited long
and multibranched-liked structures, while the MSCs cultured in regular media failed to
exhibit the abovementioned morphology (Supplementary Figure S1). After two weeks of
culturing PDLSCs and GMSCs in vitro, positive !III-tubulin immuno-staining confirmed
neurogenic differentiation. Interestingly, PDLSCs and GMSCs exhibited higher levels of
expression of ! -tubulin III than hBMMSCs (Figure 4a). However, MSCs cultured in the
absence of ! -NGF failed to express any positive staining. We also encapsulated MSCs in
different fabricated hydrogels in the presence of ! -NGF and analyzed their neurodifferentiation through immunofluorescence. MSCs encapsulated in alginate/HA with a 1:1
ratio showed higher expression levels of !III-tubulin compared to MSCs encapsulated in
hydrogels with lower concentrations of HA (Alg/HA: 4:1 and 2:1) or alginate alone
(p<0.05). Additionally, PDLSCs showed statistically greater amounts (p < 0.05) of !IIItubulin staining in comparison to GMSCs or hBMMSCs (Figure 4b and 4c). No statistically
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significant difference was observed between expression levels of GMSCs and hBMMSCs
(P<0.05).
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Gene expression analysis was performed to evaluate the molecular mechanism of neurodifferentiation of encapsulated MSCs. !III-tubulin and GFAP expression levels were
analyzed (Figure 5a). Our quantitative PCR analysis showed that PDLSCs and GMSCs both
abundantly expressed !III-tubulin and GFAP two weeks after in vitro differentiation (Figure
5a). However, our quantitative analysis of gene expression demonstrated that PDLSCs
showed higher expression levels of genes associated with neurogenic differentiation than
GMSCs or hBMMSCs (p < 0.05) (Figure 5a). Moreover, encapsulated MSCs in hydrogels
with the lowest modulus of elasticity (Alg/HA 1:1) showed statistically higher (p < 0.05)
levels of neurogenic-related gene expression than MSCs encapsulated in a matrix with
higher elasticity. These data indicate that the best condition for neural differentiation is an
alginate/HA matrix at a ratio of 1:1 w/w in the presence of ! -NGF. Additionally, Western
blot analysis results were in agreement with PCR findings showing that PDLSCs showed
higher expression levels of GFAP and !III-tubulin compared to GMSCs or hBMMSCs
(Figure 5b). Our Western blotting data showed that PDLSCs encapsulated in a softer
scaffold (alginate/HA with a 1:1 w/w ratio) exhibited a higher expression level of !IIItubulin than PDLSCs encapsulated in stiffer scaffolds (HA/alginate at 2:1 or 4:1 w/w ratios)
(Figure 5c), suggesting that the hydrogel elasticity can influence MSC differentiation
towards the neurogenic lineage. We further analyzed the role of inductive signals (NGF) on
the differentiation of encapsulated MSCs. MSCs encapsulated in alginate/HA at a 1:1 w/w
ratio without the presence of NGF exhibited very low levels of !III-tubulin expression,
while encapsulated MSCs in the presence of NGF expressed modest levels of !III-tubulin
expression (Figure 5d) confirming the importance of the presence of inductive signals on
lineage differentiation of encapsulated MSC. The same trend in gene expression levels was
obtained for hBMMSCs, PDLSCs, and GMSCs.
2.4. In vivo 3D differentiation of encapsulated MSCs

Author Manuscript

In vivo neurogenic differentiation of encapsulated PDLSCs and GMSCs was assessed four
weeks after implantation via histochemical and Immunofluorescence staining. Encapsulated
PDLSCs and GMSCs in HA/alginate hydrogel (1:1 w/w ratio) containing !-NGF were
implanted subcutaneously in immunocompromised mice. hBMMSCs encapsulated in HA/
alginate hydrogel were used as the positive control and cell-free HA/alginate hydrogel was
used as the negative one. Immunofluorescent staining was used to characterize the
neurogenic differentiation of MSCs in vivo. Extensive staining with GFAP and !III-tubulin
antibodies was observed within the regenerated tissues 4 weeks after subcutaneous
implantation (Figure 6a). We also investigated the expression of VAMP2, a synaptic protein.
Our data showed positive staining in all the tested groups (Figure 6b). Our semi-quantitative
analysis showed that engrafted PDLSCs had significantly higher expression levels of
neurogenic-related genes compared to GMSCs (p < 0.05) but not hBMMSCs (p > 0.05)
(Figure 6c). Furthermore, higher cell densities and greater numbers of cell colonies were
observed for PDLSCs and hBMMSCs, while the negative control group failed to present any
positive staining.
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3. Discussion
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Despite all the recent advances in cell therapy, biomaterials science and tissue engineering,
functional nerve regeneration is still a challenging clinical situation in regenerative medicine
and often leads to disappointing outcomes.[49] Cell therapies are considered a promising
alternative treatment modality for nerve regenerations. In this process, progenitor stem cells
will be engrafted at the defect site to promote cell differentiation toward the desired
phenotype (neurogenic tissue) based on the presence of signaling molecules (e.g.,
neurogenic factors) and physiomechanical properties of the environment.[49] Several studies
have reported the application of different types of adult stem cells (e.g., hBMMSCs,
adipose-derived stem cells, and dental pulp stem cells) for neurogenic differentiation.[50, 51]
Dental and orofacial-derived MSCs (e.e. PDLSCs and GMSCs) are unique alternatives.
These two categories of MSCs are easily available in the oral cavity; indeed, they can also be
found in dental clinics tissue waste.[27–30] However, no reports have assessed the neurogenic
regenerative capability of PDLSCs and GMSCs encapsulated in RGD modified alginate/
hyaluronic acid hydrogels. In this study, for the first time, we investigated the suitability of
PDLSCs and GMSCs delivered in this manner for nerve regeneration.

Author Manuscript
Author Manuscript

Our in vitro analysis showed that PDLSCs and GMSCs adopted the morphology of
neuronal-like cells and expressed neurogenic-associated markers after two weeks of neurodifferentiation, as confirmed by positive !III-tubulin immuno-staining. Interestingly,
PDLSCs and GMSCs exhibited higher levels of ! -tubulin III expression than hBMMSCs, a
phenomenon that might be attributed to the neural crest origin of the orofacial-derived
MSCs. Subsequently, we encapsulated PDLSCs and GMSCs in a 3D scaffold of alginate and
hyaluronic acid (HA) hydrogel containing nerve growth factor, and analyzed the fate of
MSCs via well-established in vitro and in vivo models. Studies have shown that a HA-rich
scaffold with a low elastic modulus provides a favorable environment for neural
differentiation. In addition, alginate hydrogel has been widely used in tissue engineering
applications, including nerve regeneration.[40,41] In this study, we first fabricated hydrogel
scaffolds based on alginate and HA hydrogels with different composition and elasticity. We
analyzed the influence of the biomechanical properties of the 3D hydrogels on proliferation
and differentiation of encapsulated PDLSCs and GMSCs. As expected, a higher
concentration of HA decreased the elastic modulus of the fabricated hydrogel mixture.
Interestingly, we found that the proliferation rate of GMSCs increased with a decrease in the
elasticity of the hydrogel, while scaffold elasticity did not influence the proliferation rates of
PDLSCs or hBMMSCs. Additionally, neurogenic induction assays of the encapsulated cells
showed that addition of HA to the alginate, in the presence of NGF, significantly enhanced
the neurogenic differentiation of encapsulated MSCs, as confirmed by immunostaining and
qPCR analyses. Immunostaining further revealed that MSCs encapsulated in the hydrogel
with lowest elastic modulus showed the largest amount of !-tubulin III staining.
Encapsulating biomaterial plays a fundamental role in the successful in vivo application of
MSCs in tissue engineering.[52, 53] Studies have confirmed that the porous structure of the
scaffold can be advantageous for cell attachment, proliferation and differentiation, leading to
the desired cell phenotype.[52–55] An alginate/HA hydrogel system has an ideal porous
structure, which supports cell adhesion and migration and permits transportation of oxygen,
Adv Healthc Mater. Author manuscript; available in PMC 2018 December 01.
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nutrients, waste molecules, and growth factors, influencing cell behavior and phenotype.
[52–55] In our previous studies, alginate hydrogel was utilized as a 3D scaffold for the
encapsulation of MSCs during proliferation and differentiation.[28, 29, 56] Furthermore, many
studies have shown that HA hydrogel can support differentiation of embryonic and neural
stem cells.[44–46] Therefore, in the current study, HA was added to alginate to develop a
dental-derived MSC delivery vehicle with neurogenic differentiation potential. Our results
demonstrate that the addition of HA to the alginate hydrogel can enhance cell proliferation
and neurogenic differentiation, probably due to the ability of HA to anchor to the cell
surface via CD44 cell surface receptors.[57] It has been reported that CD44 receptor is
expressed in PDLSCs and GMSCs, and that it can bind HA.[58,59] Our findings correlated
well with previous reports that an alginate/HA scaffold better promotes both proliferation
and neurogenic differentiation of encapsulated MSCs than alginate alone. The interaction of
the biomaterial matrix and the encapsulated MSCs can be facilitated by the presence of HA
and RGD tripeptide, enhancing cell adhesion and viability via increased access of cells to
oxygen, nutrients, and growth factors.[28, 29, 57]
It has to be mentioned that not only addition of HA changes the elasticity of the hydrogel
biomaterial, but also it might change the biochemical characteristics leading to enhanced
differentiation of encapsulated MSC toward nerve-like tissues. In the current study, HA also
was not utilized as a study group as the main focus of this study was on the application of
alginate hydrogel as the encapsulating biomaterial for dental- and orofacial-derived MSCs.
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In our in vivo study, immunofluorescence staining of tissues regenerated by implanted
MSCs confirmed positive staining against !-III tubulin for PDLSCs and GMSCs. Moreover,
PDLSCs showed significantly higher levels of neurogenic-related markers than GMSCs or
hBMMSCs, while GMSCs exhibited comparable expression levels of neurogenic-specific
markers to hBMMSCs. This finding is very promising as PDLSCs and GMSCs share an
advantage over hBMMSCs due to their ready availability and favorable growth properties.
We confirmed that the physiochemical properties of an encapsulating biomaterial (e.g.,
elasticity and the presence of cell binding motifs) and the presentation of signaling ligands
(e.g., NGF) regulate the viability, function, and differentiation and therefore the fate of the
implanted MSCs, leading to enhanced tissue regeneration. Our current findings suggest that
besides the elastic modulus of the encapsulating biomaterial, the biochemical
microenvironment also affects the fate of the engrafted MSCs. Another important parameter
that affects the fate of the encapsulated MSCs is the presence of inductive signals, which
direct their differentiation toward the desired lineage.

Author Manuscript

4. Conclusion
Taken together, our studies demonstrate that human periodontal ligament and gingival
tissues are promising sources of stem/progenitor cells for nerve tissue engineering
applications. We showed that the physiomechanical properties of the 3D scaffold on which
these cells were delivered significantly influenced the proliferation and differentiation of
encapsulated MSCs toward neurogenic tissues. Encapsulated GMSCs and PDLSCs within
an alginate/hyaluronic acid-based hydrogel scaffold with appropriate elasticity, in the
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presence of a suitable growth factor, possess potential to be used in repair/regeneration of
neurogenic tissues. Our findings confirmed that our 3D injectable cell delivery scaffold
based on alginate/hyaluronic acid comprises a promising modality of treatment for nerve
tissue regeneration and repair.

5. Experimental Section
MSC culture
Young healthy male individuals undergoing third molar extractions were chosen for
extraction of gingival and PDL tissues according to IRB approval. GMSCs and PDLSCs
were isolated and cultured in regular MSC culture media. Human bone marrow (hBM)
MSCs, purchased from Lonza (Lonza Inc. Walkersville, MD), were used as the control
group in this study. Passage four cells were utilized in all experiments.[23, 47]

Author Manuscript

MSC encapsulation within hydrogel biomaterial
PDLSCs, GMSCs or hBMMSCs were encapsulated in alginate/hyaluronic acid hydrogel at a
density of 2×106 cells/mL hydrogel. 5% RGD-coupled alginate hydrogel (1.2 w/v%)
(NovaMatrix FMC Biopolymer, Norway) was used after being purified and partially
oxidized (1%).[28, 29] Next, a 5% w/v solution of hyaluronic acid (Sigma-Aldrich) in PBS
was filtered (0.22 µm sterile syringe filter, Millipore) and alginate powder was added. We
fabricated three different hydrogel mixtures with different alginate/HA ratios (4:1, 2:1, and
1:1 w/w), and therefore, different elastic modulus values, and compared them to alginate
hydrogel without HA as the control.
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Recombinant human !-NGF Protein (R&D Systems Minneapolis, MN) (50 ng/mL in PBS)
was added to the HA/alginate hydrogel mixture, sterile filtered (0.22 µm filter) and freezedried under reduced pressure. Hydrogel microsphere fabrication was accomplished by
adding the alginate/HA mixture dropwise into a 100 mM CaCl2 solution. The hydrogel
microbeads formed during this process were incubated at 37°C for 45 min to complete ionic
cross-linking and washed with non-supplemented DMEM (x3). PDLSCs, GMSCs, and
hBMMSCs encapsulated in alginate were used as controls to analyze the effect of the
presence of HA on cell viability, adhesion, and neurogenesis. Cell-free HA/alginate hydrogel
was used as a negative control in this study.
Measurement of viability and proliferation of encapsulated MSCs
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A live–dead assay (Calcein AM/ethidium bromide homodimer-1, Invitrogen) was utilized to
analyze the viability of encapsulated MSCs up to two weeks after culturing in regular culture
media. NIH ImageJ software (NIH, Bethesda, MD) was used to quantify the percentage of
live cells. Additionally, the proliferation of the encapsulated MSCs was evaluated. Briefly,
after one week of culturing in regular culture media, the alginate hydrogels were dissolved
in a 15 mM sodium citrate solution. Next, extracted cells were cultured in 96-well plates and
DNA content was evaluated using CyQuant® cell proliferation assay.
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The biomechanical properties of the prepared hydrogels with different alginate/HA ratios
were measured using an Instron mechanical testing machine (Norwood, PA) at a
compression rate of 0.5 mm.min−1 ; and the elastic modulus (E) of each hydrogel was
calculated.[48] The morphology and pore sizes of the fabricated hydrogels were analyzed
using scanning electron microscopy (SEM) (JEOL 5300, Peabody, MA).[28,29] The release
profile of the NGF was evaluated using an anti-human recombinant human !-NGF ELISA
kit (Abcam). Briefly, alginate/HA microspheres containing h-NGF (50 ng/mL) were
incubated in 20 mL PBS solution at 37°C for a period of up to two weeks. At different time
intervals, the medium was collected and the amounts of released h-NGF were measured
using the ELISA kit. The amount of NGF remaining inside the hydrogel mixture was
measured via immunofluorescence staining using antibodies against h- ! NGF (Abcam).
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Next, the swelling kinetics of the fabricated hydrogels was evaluated according to the
methods already in the literature.[29] Briefly, the prepared microbeads were dried, weighed,
and immersed in distilled water at 37 °C. At every 30 min time interval, the swollen samples
were weighed and the swelling ratio (SR) was calculated.
In vitro neurogenic differentiation assay
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A neurogenic differentiation assay was performed in 2D and 3D culture conditions. To
induce neurogenic differentiation, PDLSCs, GMSCs, and hBMMSCs were cultured in
regular culture media containing human ! NGF (50 nM/mL) for two weeks, while the
culture medium was changed twice per week. After two weeks the neurogenic differentiation
of the MSCs was analyzed immunofluorescently using antibodies against ! III tubulin and
counterstaining with DAPI. MSC cultures without human ! NGF were utilized as the
negative control.
Additionally, to analyze the role of the scaffold’s mechanical properties and the role of
inductive signals on the neuro-differentiation of encapsulated MSCs, PDLSCs, GMSCs, and
hBMMSCs (2×106 cells) were encapsulated in 1 mL of HA/alginate microspheres with
different alginate/HA ratios. The constructs were cultured in regular culture media
containing human ! NGF (50 nM/mL). Cell-free HA/alginate microspheres without any
growth factor were used as the control group. Two weeks after neurogenic induction, the
specimens were fixed with 4% PFA, and paraffin sections were made. Neurogenic
differentiation was evaluated by immuno-staining using antibodies against GFAP and !IIItubulin (Abcam) at 4°C overnight, detected using Alexa fluor conjugated secondary
antibody (1:200 dilution, Invitrogen), and counterstained with DAPI.
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Quantitative real-time PCR assay and Western blot analysis
Encapsulated MSCs were recovered from hydrogel microspheres after four weeks of
neurogenic induction and total RNA was isolated using Trizol reagent (Invitrogen). RNA
was reverse-transcribed and single-stranded cDNA was synthesized using a Superscript III
cDNA synthesis kit (Invitrogen). Relative gene expression was calculated using the 2−∆∆Ct
method, with normalization to the Ct of the housekeeping gene GAPDH (glyceraldehyde 3phosphate dehydrogenase). Primer sequences are described in Table 1.
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In order to run Western blot analysis, after two weeks of neuro-induction, MSCs were
recovered from hydrogels and lysed using protein extraction buffer (Bio-Rad, Irvine, CA).
The extracted proteins were fractionated in 10% sodium dodecyl sulfate-polyacrylamide gels
(PAGE) and electrophoretically transferred to a nitrocellulose membrane (Bio-Rad). Next,
the membranes were incubated with antibodies against rabbit polyclonal glial fibrillary
acidic protein (GFAP) and ! III Tubulin antibodies (Abcam). The membranes were reprobed with an antibody against the housekeeping gene !-actin (Abcam).
Subcutaneous transplantation of encapsulated MSCs
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All of the surgical procedures were performed based on approved animal protocols. 4 × 106
PDLSCs, GMSCs, or hBMMSCs were encapsulated in HA/alginate microspheres (with
optimized elasticity and alginate/HA 1:1 ratio) loaded with ! -NGF. Approximately 10
microspheres were implanted in each subcutaneous pocket into the dorsal surfaces of mice
(5-month-old Beige nude XID III (NU/NU), Harlan, Livermore, CA). Seven mice were
tested in each group. Each animal had four different implants: 1) PDLSCs, 2) GMSCs, 3)
hBMMSCs (positive control) and 4) Cell-free hydrogel or MSC-hydrogel constructs without
human ! NGF were utilized as the negative control. Four weeks after implantation, the mice
were sacrificed, and the microspheres were harvested and stored for further analysis.
Histological, histochemical and Immunofluorescence staining
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Four weeks post-implantation, the tissues were harvested, fixed in PFA (4%) solution,
embedded in paraffin, sectioned (6 µm), and deparaffinized for staining. In order to identify
neuron-like tissue formation, the sections were stained with primary antibodies monoclonal
mouse anti- GFAP, anti-!III-tubulin and anti-VAMP-2 antibodies (1:1000, Abcam). For
immunofluorescence staining, cells were treated with 3% H2O2 and then with a blocking
buffer (1% BSA and 0.25% Triton X-100 in PBS). Specimens were washed again with PBS
and incubated with either anti- GFAP or anti-!-III tubulin primary antibody overnight.
Subsequently, the specimens were incubated with secondary Alexa-Fluor conjugated goat
anti-mouse IgG (1:200, Invitrogen) and counterstained with DAPI (Vector Laboratories,
Burlingame, CA).
Statistical Analysis
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Kolmogorov-Smirnov (K-S) (Normality test) test was performed (using SPSS software) to
determine whether our obtained data were normally distributed or not. Based on the results
of our normality test, the Kruskal-Wallis rank sum test or one-way ANOVA were used to
analyze the data at a significance level of " = 0.05. Also, two-tailed Student’s t-tests were
utilized for pairwise comparisons whenever needed. Quantitative data are expressed as mean
± standard deviation (SD).

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.

The viability of the encapsulated PDLSCs, GMSCs, and hBMMSCs: (a) Live/dead staining
of hBMMSCs, GMSCs and PDLSCs encapsulated in alginate/HA hydrogel microspheres
after one week of culturing in regular culture media. (b) Percentage of live cells measured at
different time points, indicating that more than 79% of encapsulated MSCs remained viable
for three weeks.
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Figure 2.

Characterization of fabricated hydrogel microspheres and proliferation of encapsulated
MSCs: (a) Elastic modulus of the fabricated hydrogel microspheres with different Alg/HA
ratios. (b) SEM image of fabricated alginate/HA hydrogels confirming their micro-porous
structure of the hydrogel matrix. (c) The average pore size for the fabricated hydrogels based
on SEM images. (d) Influence of composition of the fabricated hydrogel on the proliferation
of encapsulated MSCs. (e) The relationship between the elastic modulus of the
encapsulating biomaterial (alginate/HA 1:1), type of MSC, and the proliferation rate of each
type of cell. Six independent specimens per group were analyzed in each study. * p<0.05.
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Figure 3.
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Release profile characterization: (a) In vitro release profile characterization of human !NGF from alginate/HA hydrogels, confirming sustained release of !-NGF. A slight increase
in the initial release of the growth factor was observed from the softer hydrogel mixture with
the higher concentration of HA; however, no significant difference was observed in release
rates of growth factors from the different scaffolds (p > 0.05), and both exhibited first-order
kinetics. (b) Immunofluorescence staining against anti-!-NGF antibodies showing the
retained NGF ligands remained within alginate/HA with 4:1, 2:1, 1:1 ratios and alginate
alone after 14 days. (c) Semi-quantitative analysis of retained NGF ligands in panel b. (d)
Swelling properties of the fabricated hydrogels and the effects of the HA ratio. Six
independent specimens per group were analyzed in each study. *P <0.05, NS: not
significant.
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Figure 4.

In vitro neurogenic differentiation of encapsulated MSCs. (a) Immunofluorescence staining
against !-tubulin III antibodies for hBMMSCs, PDLSCs, and GMSCs after two weeks of
neurogenic induction assay. The effects of presence or absence of beta NGF was analyzed.
(b) Immunofluorescence staining against !-tubulin III antibodies for encapsulated MSCs
against !-tubulin III antibodies showing positively staining for all the tested MSCs in
different hydrogel scaffolds. hBMMSCs encapsulated in hydrogel without NGF was utilized
as the control and failed to express any positive staining. (c) The percentage of positive
stained cells (from panel b) for MSCs encapsulated in hydrogel microspheres. Six
independent specimens per group were analyzed in each study. *P <0.05, **P <0.01, NS: not
significant.
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Figure 5.

Molecular analysis of neuro-differentiation of encapsulated MSCs. (a) The expression levels
of !-tubulin III and glial fibrillary acidic protein (GFAP) genes after 14 days of neurogenic
induction in vitro, analyzed using RT-PCR. (b) Western blot analysis exhibiting the
expression levels of neurogenic regulator gene GFAP and !-tubulin III in MSCs
encapsulated in Alg/HA 1:1 hydrogel mixture. The levels of GFAP and !-tubulin III
expression were higher for PDLSCs than for hBMMSCs and GMSCs. (c) Expression levels
of !-tubulin III for encapsulated PDLSCs confirming that application of the hydrogel
biomaterial with lower elastic modulus led to enhanced !-tubulin III expression levels (d)
Presence of inductive signal (NGF) led to greater !-tubulin III expression levels for
encapsulated MSCs in alginate/HA hydrogel with 1:1 w/w ratio. Six independent specimens
per group were analyzed in each study. *P <0.05, NS: not significant.
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Figure 6.

Subcutaneous transplantation of encapsulated MSCs in HA/alginate hydrogel with 1:1 w/w
ratio: (a) Immunofluorescence staining for early neural differentiation markers GFAP (red)
and ! III-tubulin (green); and (b) pre-synaptic marker VAMP2 and the effects of presence of
beta NGF. (c) The percentage of positive cells for VAMP2 antibody in each specimen
according to immunostaining results of panel b. *P <0.05, NS: not significant.
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Oligonucleotide primers used in RT-PCR analysis.
Gene

Sequence

Amplification
(bp)

GFAP

Sense: 5’-GGAGAGGGGACAACTTTGCAC -3’

164

Antisense: 5’-CCAGCGATTCAACCTTTCTC -3’

!-tubulin III

Sense: 5’- TTCTGGTGGACTTGGAACCT-3’

180

Antisense: 5’- ACTCTTTCCGCACGACATCT-3’

Glyceraldehyde 3-phosphate dehydrogenase (GADPH)

Sense: 5’-AGCCGCATCTTCTTTTGCGTC-3’:
Antisense: 5’-TCATATTTGGCAGGTTTTTCT-3’
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